This study is looking into how the body stores and releases sodium (salt) without water, especially in people with peritoneal dialysis (PD) and heart failure. You would receive either 5% Dextrose/Water or 1.5% standard PD fluid for five days. After a six-week break, you would then receive the other treatment for another five days. Researchers want to see if a significant amount of sodium can be stored and released in the body, and where this happens. To join, you must be an adult (18+) with end-stage renal disease (ESRD) on PD, have stable blood pressure (above 130 mmHg systolic), and a serum sodium level above 135 mmol/L. The study aims to measure how much water-free sodium is removed over the five-day treatment periods. The current recruitment status is unclear, and the study plans to enroll 10 participants.

Study design

This is a randomized, blinded crossover study where participants will receive two different treatments over time. The study plans to enroll 10 participants.

What's involved

You would receive one treatment for 5 days, followed by a 6-week break, and then the alternate treatment for another 5 days. Water-free sodium removal will be measured daily during the treatment periods.

Compensation

Not stated in the trial record.

Follow-up

Water-free sodium removal is measured daily for 5 days during each treatment period. There is a 6-week washout period between treatments.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.